Peking University People's Hospital: Anemia, Aplastic trials

The registry lists 10 Anemia, Aplastic studies with Peking University People's Hospital as lead sponsor. 9 are open to participants now and 0 have results posted.

Phase 1 2Phase 2 3Phase 3 1Phase 4 1No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Thiotepa-Based Conditioning for Haploidentical Hematopoietic Stem Cell Transplantation in Older Patients With Severe Aplastic AnemiaNot yet recruitingNCT07819812
• Sirolimus+Ruxolitinib+Mycophenolate Mofetil for Prophylaxis of aGVHD in Patients Receiving Haplo-HSCT Who Are Intolerant to CNINot yet recruitingNCT07796620Phase 1/2
• Prophylactic NAC to Improve Platelet Engraftment After Haploidentical Transplantation in Severe Aplastic Anemia PatientsNot yet recruitingNCT07737262Phase 3
• Peripheral Blood Versus Bone Marrow Plus Peripheral Blood Grafts for Haploidentical Transplantation in Severe Aplastic AnemiaRecruitingNCT07629947Not applicable
• A Novel Conditioning Regimen for Haplo-HSCT in Older Patients With SAARecruitingNCT07586735
• A Prediction Model in Pregnant Women With Aplastic AnemiaRecruitingNCT07101770
• NAC for Hematopoietic Recovery in SAANot yet recruitingNCT06518044Phase 2
• Sirolimus+Abatacept+Mycophenolate Mofetil for Prophylaxis of aGVHD in Patients Receiving Haplo-HSCT Who Are Intolerant to Calcineurin InhibitorsNot yet recruitingNCT06279494Phase 1/2
• The Optimization of Conditioning Regimen for HLA Matched HSCT in SAARecruitingNCT06069180Phase 4
• Risk Stratification Directed Conditioning Regimen for Haploidentical HSCT in SAAStatus unknownNCT03821987Not applicable